USPH (USPH) Q2 2026 Earnings Call Transcript
US Physical Therapy (USPH) discussed its Q2 2026 results and hospital-affiliation rollout. The company said Q2 revenue rose 8.5% to $214M, PT revenue rose 8.4% to $182M, and visits increased 6.6% to 1.662M. Net rate was $107.59. It cited $3.2M higher self-insured health care costs and expects clinic transitions to continue into Q3.
How this was made
The 30-second read
Why it matters
Key trading takeaways are the magnitude of visit growth and net-rate improvement, the quantified claims-driven cost headwind ($3.2M difference year-to-date), and the expected acceleration of clinic transitions in Q3 (plus Gulf Coast by end of month).
Market read
This is a company-specific earnings disclosure with multiple forward-looking operational milestones (Q3 clinic transitions, Gulf Coast partnership timing) and margin/cost drivers that can change near-term estimates.
What to watch
The transcript mentions a finance and HR systems upgrade go-live at the beginning of 2027; execution risk around that transition could affect operating efficiency and reported margins.
Background
USPH’s Q2 2026 call focuses on physical therapy (PT) and industrial injury prevention (IIP) performance, with emphasis on transitioning metro clinics into hospital affiliations (notably NYU Langone).
Ticker impact
USPH reported Q2 2026 results and detailed hospital-affiliation clinic rollout, including $107.59 net rate and 8.5% revenue growth.
Near-term sentiment likely positive on strong volume and net-rate metrics, with watch items around margin pressure from claims and rollout costs.
The transcript provides multiple decision-relevant datapoints: revenue, visits, net rate, margin comparisons, and the expected Q3 clinic integration cadence plus a $3.2M claims swing that informed guidance.
Market effects
Reinforces demand strength and pricing power in outpatient physical therapy, while highlighting margin sensitivity to employee medical claims and rollout costs.
Metro and Gulf Coast partnership transitions are positioned as key regional growth drivers into Q3 and 2027.
Limited, as the disclosure is company-specific to USPH’s clinic network and hospital affiliations.
Counterpoint
The strong visit and net-rate metrics may not translate into sustained earnings if PT gross margin remains pressured longer than management expects due to claims volatility and continued front-loading.
Key entities
- companyUSPH
US Physical Therapy, Inc., reporting Q2 2026 revenue, visits, net rate, margins, and hospital-affiliation rollout progress.
- partnerNYU Langone
Hospital affiliation partner referenced as supporting metro clinic volume translation.
